Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: A prospective cohort studyResearch paper Published on 2021-11-292022-10-31 Journal: EClinicalMedicine [Category] COVID-19, [키워드] 95% CI 95% confidence interval B.1.351 Beta BNT162b2 BNT162b2 vaccine caused CIs cohort analysis collected concern conducted Contact country COVID-19 COVID-19 vaccine died dominant dose effective Effectiveness Epidemiology estimate event Evidence finding funding Hospitalized Infection infection risk infections International mandatory Ministry of Health MoH mRNA mRNA vaccines neutralizing antibody of BNT162b2 pandemic PCR-positive Pfizer prevention prospective cohort study prospective observational study raising SARS-CoV-2 SARS-CoV-2 variant second dose Sequencing South Africa specimen strain study period symptomatic tested through contact Vaccine vaccine effectiveness variant Beta (B.1.351) was performed WGS whole genome [DOI] 10.1016/j.eclinm.2021.101190 PMC 바로가기 [Article Type] Research paper
PICK-ing Malaysia’s Epidemic Apart: Effectiveness of a Diverse COVID-19 Vaccine PortfolioArticle Published on 2021-11-242022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] AZD1222 BNT162b2 Cohort cohort study confirmed COVID-19 case CoronaVac COVID-19 COVID-19 cases COVID-19 infection COVID-19 vaccine COVID-19 vaccines death deaths effective Effectiveness evaluated ICU admission Infection Logistic regression Malaysia predominant retrospective cohort SARS-CoV-2 screening method symptomatic vaccination Vaccine vaccine effectiveness [DOI] 10.3390/vaccines9121381 PMC 바로가기 [Article Type] Article
Vaccine versus Variants (3Vs): Are the COVID-19 Vaccines Effective against the Variants? A Systematic ReviewReview Published on 2021-11-102022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] adopted B.1.1.7 B.1.351 B.1.617.2 Beta Case-control case-control studies clinical trials cohorts conducted COVID-19 COVID-19 vaccine criteria Delta doses effective Effectiveness Efficacy eligibility Gamma Google Scholar Inclusion inclusion criteria indicate Mutation new SARS-CoV-2 observational studies offer other variants P.1 phase PROTECT protection raised recommendation reported Research retrospective cohorts review SARS-CoV-2 Spread Strains systematic review test negative unique vaccinated individual vaccinated individuals vaccination Vaccine vaccine effectiveness vaccine efficacy variant variants variants of concern [DOI] 10.3390/vaccines9111305 PMC 바로가기 [Article Type] Review
Presence of defective viral genes in H1N1 live attenuated influenza vaccine strains is not associated with reduced human cell fitness or vaccine effectivenessArticle Published on 2021-11-052023-06-23 Journal: Vaccine [Category] 신종인플루엔자, [키워드] defective interfering particles defective viral genomes Fluenz FluMist Influenza virus live attenuated influenza vaccine vaccine effectiveness [DOI] 10.1016/j.vaccine.2021.10.011
Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 20212021년 8월부터 9월까지 네덜란드 델타 변종(B.1.617.2)이 우세한 동안 가정 접촉자에 대한 SARS-CoV-2 전파에 대한 백신 효과Rapid Communication Published on 2021-11-042022-09-10 Journal: Eurosurveillance [Category] MERS, SARS, 변종, [키워드] 95% CI 95% confidence interval addition attack rates B.1.617.2 collected Contact Contact tracing COVID-19 delta variant dominant Effectiveness household contact household contacts household study index case index cases Infection Netherlands onward transmission SARS-CoV-2 SARS-CoV-2 transmission SARS-CoV-2 vaccine secondary attack rate Transmission vaccination vaccine effectiveness [DOI] 10.2807/1560-7917.ES.2021.26.44.2100977 PMC 바로가기 [Article Type] Rapid Communication
Effectiveness of BNT162b2 Vaccine in Adolescents during Outbreak of SARS-CoV-2 Delta Variant Infection, Israel, 20212021년 이스라엘, SARS-CoV-2 델타 변종 감염 발생 시 청소년에서 BNT162b2 백신의 효과Dispatch Published on 2021-11-012022-09-10 Journal: Emerging Infectious Diseases [Category] MERS, SARS, 변종, [키워드] 2019 novel coronavirus disease acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Adolescent adolescents approved B.1.617.2 BNT162b2 BNT162b2 vaccine coronavirus coronavirus disease COVID-19 Delta delta variant effective Effectiveness evaluated Infection Israel of BNT162b2 outbreak respiratory respiratory infections SARS-CoV-2 severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 the vaccine Vaccine vaccine effectiveness viruses zoonoses [DOI] 10.3201/eid2711.211886 PMC 바로가기 [Article Type] Dispatch
Age-Specific Etiology of Severe Acute Respiratory Infections and Influenza Vaccine Effectivity in Prevention of Hospitalization in Russia, 2018–2019 SeasonResearch Article Published on 2021-10-282023-06-08 Journal: Journal of Epidemiology and Global Health [Category] 신종인플루엔자, [키워드] Hospitalization Influenza respiratory viruses vaccine effectiveness [DOI] 10.1007/s44197-021-00009-1 PMC 바로가기 [Article Type] Research Article
Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness Among Adults in the United States, 2019–2020: A Test-Negative StudyArticle Published on 2021-10-152023-06-14 Journal: Clinical Infectious Diseases: An Official Publicat [Category] Fulltext, 신종인플루엔자, [키워드] Critical illness immunization Influenza vaccination vaccine effectiveness [DOI] 10.1093/cid/ciab462 PMC 바로가기
Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection with the Delta (B.1.617.2) variant: second interim results of a living systematic review and meta-analysis, 1 January to 25 August 2021Delta(B.1.617.2) 변이형 SARS-CoV-2 감염에 대한 COVID-19 백신의 효과: 살아있는 체계적인 검토 및 메타 분석의 두 번째 중간 결과, 2021년 1월 1일부터 8월 25일까지Meta-Analysis Published on 2021-10-142022-09-10 Journal: Eurosurveillance [Category] MERS, SARS, 변종, [키워드] 95% CI 95% confidence interval Alpha Alpha variant asymptomatic infection B.1.617.2 COVID-19 COVID-19 vaccine Delta delta variant dominant Effectiveness endpoints Evidence hospitalisation investigated Meta-analysis Mild outcome SARS-CoV-2 SARS-COV-2 infection severe COVID-19 symptomatic infection systematic review vaccination vaccine effectiveness variant of concern was reduced [DOI] 10.2807/1560-7917.ES.2021.26.41.2100920 PMC 바로가기 [Article Type] Meta-Analysis
Neutralization of Delta variant with sera of Covishield™ vaccinees and COVID-19-recovered vaccinated individualsCovishield™ 백신 접종자 및 COVID-19 회복 백신 접종 개인의 혈청으로 Delta 변이체 중화Article Published on 2021-10-112022-09-11 Journal: Journal of Travel Medicine [Category] MERS, SARS, 변종, 진단, [키워드] Abstract Adenoviral-vector vaccines AstraZeneca AZD1222 ChAdOx-1 delta variant sera vaccinated individual Vaccine vaccine effectiveness vaccinee variants variants of concern [DOI] 10.1093/jtm/taab119 PMC 바로가기 [Article Type] Article